Skip to main content
. Author manuscript; available in PMC: 2019 Jul 22.
Published in final edited form as: J Clin Immunol. 2018 Jul 25;38(6):646–655. doi: 10.1007/s10875-018-0537-4

Table 2.

Autoimmune manifestations in 134 patients with CID-G/AI or with AS

Manifestation CID-G/AI (n = 68) N (%) AS (n = 66) N (%)
Cytopenias 36 (53) 38 (57.6)
AIHA 25 (36.7) 33 (50)
ITP 17 (25) 11 (16.6)
AIN 15 (22.1) 8 (12.2)
IBD, enteropathy 9 (13.2)
Vitiligo 8 (11.7)
Hypo/hyper-thyrodism 7 (10.3) 1 (1.5)
Vasculitis 6 (8.8) 3 (4.5)
Alopecia 5 (7.4) 1 (1.5)
Liver disease 4 (5.9) 1 (1.5)
Autoimmune neuropathies 4 (5.9)
Autoimmune myopathies 4 (5.9)
Nephritis 3 (4.4) 1 (1.5)

AIHA, autoimmune hemolytic anemia; AIN, autoimmune neutropenia; AS, atypical SCID; CID-G/AI, combined immune deficiency with granuloma and/or autoimmunity; IBD, inflammatory bowel disease; ITP, immune thrombocytopenia